Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Falk

Showing results (551-560 of 580) with videos related to

Pageof 58
Sort By:
Frontiers in Immunology|December 30, 2021
Donor NK and T Cells in the Periphery of Lung Transplant Recipients Contain High Frequencies of Killer Cell Immunoglobulin-Like Receptor-Positive SubsetsAnna-Maria Hitz, Kim-Alina Bläsing, Bettina Wiegmann, et al.
Nature Immunology|November 10, 2020
CRELD1 modulates homeostasis of the immune system in mice and humansLorenzo Bonaguro, Maren Köhne, Lisa Schmidleithner, et al.
ESMO Open|June 25, 2026
Prognostic markers, quality of life (QoL) and value of health (V-He) in advanced biliary cancers (ABC) treated with second-line active symptom control (ASC) alone or ASC with oxaliplatin-5-FU chemotherapy (ASC + FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 clinical trialA Lamarca, D H Palmer, H S Wasan, et al.
Frontiers in Immunology|May 27, 2022
Insights Into Immunothrombotic Mechanisms in Acute Stroke due to Vaccine-Induced Immune Thrombotic ThrombocytopeniaNicole de Buhr, Tristan Baumann, Christopher Werlein, et al.
JHEP Reports : Innovation in Hepatology|December 9, 2025
From model to man: Understanding Tregs' dual role in MASLDJanine Dywicki, Laura Elisa Buitrago-Molina, Anna K Baumann, et al.
Journal of Hepatology|May 31, 2024
Plasma immune signatures can predict rejection-free survival in the first year after pediatric liver transplantationEvgeny Chichelnitskiy, Imeke Goldschmidt, Louisa Ruhl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2025
Targeting BCL11B in CAR-engineered lymphoid progenitors drives NK-like cell development with prolonged anti-leukemic activityFranziska Baatz, Arnab Ghosh, Jessica Herbst, et al.
Elife|June 22, 2021
Restored TDCA and valine levels imitate the effects of bariatric surgeryMarkus Quante, Jasper Iske, Timm Heinbokel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2012
Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety reportA F C Okines, R E Langley, L C Thompson, et al.
Plos One|July 30, 2014
Anti-HDV IgM as a marker of disease activity in hepatitis deltaAnika Wranke, Benjamin Heidrich, Stefanie Ernst, et al.
Pageof 58

Showing results (551-560 of 580) with videos related to

Sort By:
Pageof 58
Frontiers in Immunology|December 30, 2021
Donor NK and T Cells in the Periphery of Lung Transplant Recipients Contain High Frequencies of Killer Cell Immunoglobulin-Like Receptor-Positive SubsetsAnna-Maria Hitz, Kim-Alina Bläsing, Bettina Wiegmann, et al.
Nature Immunology|November 10, 2020
CRELD1 modulates homeostasis of the immune system in mice and humansLorenzo Bonaguro, Maren Köhne, Lisa Schmidleithner, et al.
ESMO Open|June 25, 2026
Prognostic markers, quality of life (QoL) and value of health (V-He) in advanced biliary cancers (ABC) treated with second-line active symptom control (ASC) alone or ASC with oxaliplatin-5-FU chemotherapy (ASC + FOLFOX) in the randomised phase III, multicentre, open-label ABC-06 clinical trialA Lamarca, D H Palmer, H S Wasan, et al.
Frontiers in Immunology|May 27, 2022
Insights Into Immunothrombotic Mechanisms in Acute Stroke due to Vaccine-Induced Immune Thrombotic ThrombocytopeniaNicole de Buhr, Tristan Baumann, Christopher Werlein, et al.
JHEP Reports : Innovation in Hepatology|December 9, 2025
From model to man: Understanding Tregs' dual role in MASLDJanine Dywicki, Laura Elisa Buitrago-Molina, Anna K Baumann, et al.
Journal of Hepatology|May 31, 2024
Plasma immune signatures can predict rejection-free survival in the first year after pediatric liver transplantationEvgeny Chichelnitskiy, Imeke Goldschmidt, Louisa Ruhl, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 16, 2025
Targeting BCL11B in CAR-engineered lymphoid progenitors drives NK-like cell development with prolonged anti-leukemic activityFranziska Baatz, Arnab Ghosh, Jessica Herbst, et al.
Elife|June 22, 2021
Restored TDCA and valine levels imitate the effects of bariatric surgeryMarkus Quante, Jasper Iske, Timm Heinbokel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2012
Bevacizumab with peri-operative epirubicin, cisplatin and capecitabine (ECX) in localised gastro-oesophageal adenocarcinoma: a safety reportA F C Okines, R E Langley, L C Thompson, et al.
Plos One|July 30, 2014
Anti-HDV IgM as a marker of disease activity in hepatitis deltaAnika Wranke, Benjamin Heidrich, Stefanie Ernst, et al.
Pageof 58